Less Ads, More Data, More Tools Register for FREE

Pin to quick picksADV.L Regulatory News (ADV)

  • There is currently no data for ADV

Offer Update

21 Aug 2009 18:08

RNS Number : 8626X
Fairfax Financial Holdings Limited
21 August 2009
 

Not for release, publication or distribution, in whole or in part, in OR into Australia or Japan or any OTHER Jurisdiction if to do so would constitute a violation of the relevant laws of such Jurisdiction.

RNS Number0753A

Fairfax Financial Holdings Limited

21 August 2009

Fairfax Financial Holdings Limited ("Fairfax") recommended cash offer for Advent Capital (Holdings) PLC ("Advent") 

Offer Unconditional as to Acceptances

On 17 July 2009, the Fairfax Board and the Independent Advent Directors announced the terms of a recommended cash offer under which Fairfax (on behalf of itself and other members of the Fairfax Group) would acquire the entire issued and to be issued ordinary share capital of Advent not already owned by the Fairfax Group. The Offer Document setting out the full terms and conditions of the Offer was posted to Advent Shareholders on 31 July 2009.

The Fairfax Board is now pleased to announce that the Offer for Advent has become unconditional as to acceptances following satisfaction of the acceptance condition set out in paragraph (a) of Part A of Appendix I to the Offer Document. The Offer remains subject to the conditions set out in paragraphs (b) to (i) of Part A of Appendix I to the Offer Document. The Offer is being extended and will remain open until further notice.

Level of Acceptances and Ownership

The Fairfax Board announces that, as at 1.00 p.m. (London time) on 21 August 2009 (the First Closing Date), valid acceptances of the Offer had been received from Advent Shareholders in respect of a total of 13,276,428 Advent Shares, representing approximately 98.04 per cent. of the issued Advent Shares to which the Offer relates (and approximately 32.65 per cent of the existing issued share capital of Advent). 

The total acceptances include valid acceptances of the Offer received from all of the Independent Advent Directors in respect of 1,951,064 Advent Shares, Trevor Ambridge (who, being a director of Advent and a Vice President of Fairfax, is deemed to be acting in concert with Fairfax for the purposes of the Offer) in respect of 46,000 Advent Shares and Mackenzie Cundhill Investment Management Limited in respect of 5,168,090 Advent Shares, which together comprise approximately 52.92 per cent. of the issued Advent Shares to which the Offer relates (and approximately 17.62 per cent of the existing issued share capital of Advent) and which are the subject of irrevocable undertakings to accept the Offer as described in the Offer Document. Neither Fairfax nor its associates have any other outstanding irrevocable commitments or letters of intent to accept the Offer.

Having received acceptances in respect of not less than 90 per cent. in nominal value of the Advent Shares to which the Offer relates and not less than 90 per cent. of the voting rights carried by those shares, Fairfax is pleased to announce that the Offer has become unconditional as to acceptances.

No acceptances have been received from any persons acting or deemed to be acting in concert with Fairfax other than the acceptance from Trevor Ambridge referred to above.

In addition to the Advent Shares in respect of which Fairfax has received acceptances of the Offer, Fairfax Offer Shareholders own 27,116,255 Advent Shares, representing approximately 66.70 per cent. of the existing issued share capital of Advent.

Save as disclosed above, neither Fairfax nor, so far as Fairfax is aware, any person acting in concert with Fairfax held any Advent Shares or interests in or rights to subscribe for Advent Shares before the start of the Offer Period, nor have they acquired or agreed to acquire any Advent Shares or rights over Advent Shares since that date and nor do they have any short position in relation to Advent Shares (whether conditional or absolute and whether in money or otherwise) including any short position under any derivative, any agreement to sell or any delivery obligation or right to require another person to purchase or take delivery of any Advent Shares. 

Neither Fairfax nor, so far as Fairfax is aware, any person acting in concert with Fairfax has borrowed or lent any Advent Shares nor has any arrangement in relation to Advent Shares been made. For these purposes, "arrangement" includes any indemnity or option arrangement, any agreement or understanding, formal or informal, of whatever nature, relating to Advent Shares which is, or may be, an inducement to deal or refrain from dealing in such shares. 

Extension of Offer

The Fairfax Board announces that the Offer, which remains subject to the terms and conditions set out in paragraphs (b) to (i) of Part A of Appendix I to the Offer Document and to the other terms  referred to in the Offer Document, will remain open for acceptance until further notice. 

Copies of the Offer Document are available from Capita Registrars, Corporate Actions, The Registry, 34 Beckenham RoadBeckenhamKent BR3 4TU

Further Acceptance of the Offer

Advent Shareholders who wish to accept the Offer but have not yet done so are urged to do so as soon as possible. 

For holders of Advent Shares held in certificated form (that is, not held in CREST), Forms of Acceptance not yet returned should be completed, signed and returned in accordance with the instructions set out in paragraph 12(a) of the letter from Fairfax in Part II of the Offer Document and also Parts B and C of Appendix I to the Offer Document and in the Form of Acceptance as soon as possible.

For holders of Advent Shares held in uncertificated form (that is, held in CREST), a TTE Instruction should be submitted in accordance with the instructions set out in paragraph 12(b) of the letter from Fairfax in Part II of the Offer Document and also Parts B and D of Appendix I to the Offer Document as soon as possible.

Full details of how to accept the Offer in respect of certificated and uncertificated Advent Shares are set out in the Offer Document and, in the case of certificated Advent Shares only, the accompanying Form of Acceptance. 

Compulsory acquisition of Advent Shares and Delisting 

As stated in the Offer Document, assuming that the Offer becomes or is declared wholly unconditional, Fairfax intends to exercise its rights pursuant to Chapter 3 of Part 28 of the Companies Act 2006 to acquire compulsorily the remaining Advent Shares in respect of which the Offer has not been accepted on the same terms as the Offer.

Assuming the Offer becomes or is declared unconditional in all respects, and provided that Fairfax (together with other members of the Fairfax Group) has acquired or agreed to acquire 75 per cent. of the voting rights attached to the Advent Shares, Fairfax intends to procure the making of an application by Advent to the London Stock Exchange for the Delisting of the issued Advent Shares in accordance with the AIM Rules and for Advent to be converted into a private limited company. In this event, it is anticipated that Delisting will take effect no earlier that 20 clear Business Days after Fairfax has acquired or agreed to acquire 75 per cent. of the voting rights attaching to the issued Advent Shares.

If Advent were to Delist, the remaining Advent Shareholders will become minority shareholders in a privately controlled unlisted company. This would significantly reduce the liquidity and marketability of any Advent Shares not assented to the Offer. In this event, remaining Advent Shareholders may be unable to sell their Advent Shares and there can be no certainty that any dividends or other distributions will be made by Advent or that the Advent Shareholders will again be offered as much as the Offer Price for the Advent Shares held by them.

Save as defined above, capitalised terms used in this announcement have the same meaning as in the Offer Document dated 31 July 2009 ("Offer Document")

Enquiries:

Fairfax Financial Holdings Limited

Greg Taylor - Chief Financial Officer +1 416 367 4941

Merrill Lynch International (Financial Advisor to Fairfax) +44 (0) 20 7628 1000

Matthew Watkins

Paul Frankfurt 

The Fairfax Directors accept responsibility for the information contained in this announcement. To the best of the knowledge and belief of the Fairfax Directors (who have taken all reasonable care to ensure that such is the case), the information contained in this announcement is in accordance with the facts and does not omit anything likely to affect the import of such information. 

Merrill Lynch, which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting exclusively for Fairfax and no one else in connection with the Offer and will not be responsible to anyone other than Fairfax for providing the protections afforded to its customers or for providing advice in relation to the Offer or in relation to the contents of this announcement or any transaction or arrangement referred to therein.

This announcement is not intended to and does not constitute, or form any part of, an offer or an invitation or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities or the solicitation of any vote or approval in any jurisdiction pursuant to the Offer or otherwise. The Offer is subject to the terms and conditions set out in the Offer Document and, in the case of certificated Advent Shares, in the Form of Acceptance. The Offer Document includes details of how to accept the Offer. Any acceptance or other response to the Offer should be made only on the basis of the information contained in the Offer Document and, in the case of certificated Advent Shares, the Form of Acceptance.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
OUPCKDKPABKDFFB
Date   Source Headline
15th Jul 20147:00 amRNSSale of Interest in Mariola Thermal Coal Project
19th May 20147:00 amRNSInvestment Update
28th Mar 20142:56 pmRNSDirector/PDMR Shareholding
19th Mar 20147:00 amRNSInvestment Update
13th Mar 20144:16 pmRNSPlacing and Equity swap
18th Feb 20147:00 amRNSINVESTMENT UPDATE
28th Jan 20147:00 amRNSInvestment Update
24th Jan 20147:00 amRNSPlacing
16th Jan 20147:00 amRNSHalf Yearly Report
18th Dec 20137:00 amRNSOption Agreement
13th Dec 201310:44 amRNSIssue of Equity
12th Dec 20139:25 amRNSHolding(s) in Company
11th Dec 20133:41 pmRNSHolding(s) in Company
9th Dec 20137:00 amRNSCompletion of Proposals
29th Nov 20133:53 pmRNSChange of Name
29th Nov 20131:55 pmRNSShare Price Movement
22nd Nov 201312:21 pmRNSResult of AGM
31st Oct 20137:00 amRNSCircular to Shareholders and AGM Notice
15th Oct 20137:00 amRNSFinal Results
25th Sep 20139:58 amRNSInterim Dividend Payment
13th Sep 20139:38 amRNSSale of Agricultural Assets - Update
16th Aug 201311:34 amRNSSale of Agricultural Assets - Update
29th Jul 201312:17 pmRNSDirector/PDMR Shareholding
18th Jul 201310:41 amRNSDirector/PDMR Shareholding
16th Jul 20137:00 amRNSInvestment Update
21st Jan 20137:00 amRNSHalf Yearly Report
10th Dec 20127:00 amRNSSale of Agricultural Assets - Update
27th Nov 201212:36 pmRNSResult of AGM
20th Nov 201211:27 amRNSDividend Declaration
13th Nov 201212:00 pmRNSAdvisor change of name
30th Oct 201210:24 amRNSAnnual Financial Report
23rd Oct 201212:13 pmRNSAnnual Financial Report
22nd Oct 20127:00 amRNSFinal Results
15th Aug 20128:23 amRNSInvestment update
1st Jun 20127:00 amRNSSale of Agricultural Asset
30th Jan 20127:00 amRNSHalf Yearly Report
16th Jan 20123:55 pmRNSHolding(s) in Company
6th Jan 20127:00 amRNSTotal Voting Rights
29th Dec 20112:10 pmRNSDirectorate Change
1st Dec 20117:00 amRNSDividend Declaration
29th Nov 201111:46 amRNSResult of AGM
25th Nov 20117:00 amRNSGrant of Option
26th Oct 20112:26 pmRNSAnnual Financial Report
26th Oct 20117:00 amRNSAnnual Financial Report
25th Aug 201110:03 amRNSOption Agreement Reached on Unialco Stake
18th Aug 201110:01 amRNSHolding(s) in Company
31st Jan 20118:18 amRNSHalf Yearly Report
1st Dec 201012:06 pmRNSResignation of Director
24th Nov 20104:38 pmRNSResult of AGM
1st Nov 20103:56 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.